Successful treatment of perforating granuloma annulare with 0.1% tacrolimus ointment

Journal of Dermatological Treatment

Volumn 19, Issue 6, 2008, Pages 376-377

  Lopez Navarro, Norberto ^a,b   Castillo, Rosa ^a   Gallardo, María A ^a   Alcaide, Antonio ^a   Matilla, Alfredo ^a   Herrera, Enrique ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE   (Spain)

Author keywords

Perforating granuloma annulare; Tacrolimus; Treatment

Indexed keywords

CIPROFLOXACIN; CLOBETASOL; CLOXACILLIN; CORTICOSTEROID; STEROID; TACROLIMUS;

AGED; ARTICLE; CASE REPORT; DIABETES MELLITUS; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRANULOMA ANNULARE; HISTIOCYTE; HUMAN; HYPERPIGMENTATION; LYMPHOCYTE; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; EXTREMITIES; FEMALE; GRANULOMA ANNULARE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SKIN ULCER; TACROLIMUS; TREATMENT OUTCOME;

EID: 56549094819     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630802132650     Document Type: Article

References (6)

1. Muhlemann MF, Williams DR. Localized granuloma annulare is associated with insulin-dependent diabetes mellitus. Br J Dermatol. 1984;111:325-9.
2. Ratnavel RC, Norris PG. Perforating granuloma annulare: Response to treatment with isotretinoin. J Am Acad Dermatol. 1995;32:126-7.
3. Penas PF, Jones-Caballero M, Fraga J, Sánchez-Pérez J, García-Díez A. Perforating granuloma annulare. Int J Dermatol. 1997;36:340-8.
4. Mempel M, Musette P, Flageul B, Schnopp C, Remling R, Gachelin G, et al. T-cell receptor repertoire and cytokine pattern in granuloma annulare: Defining a particular type of cutaneous granulomatous inflammation. J Invest Dermatol. 2002;118:957-66.
5. Harth W, Linse R. Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br J Dermatol. 2004;150:792-4.
6. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol. 2005;152:581-2.